UBS Group
AVNS

UBS Group’s Avanos Medical AVNS Stock Holding History

UBS Group’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-300
Closed -$14K – 8793
2014
Q4 		$14K Buy
+300
New +$11.8K ﹤0.01% 8075

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

UBS Group's AVNS Position: Q1 2026 in Review

UBS Group reduced its Avanos Medical (AVNS) stake by 68% in Q1 2026, selling an estimated $3.8M and leaving 132,735 shares worth $1.86M. The position accounts for ﹤0.01% of the portfolio, ranked #5042.

UBS Group first reported a position in AVNS in Q4 2014 and has held it in 46 quarters since. The position peaked at $10.2M in Q4 2014. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • UBS Group held 132,735 shares of Avanos Medical worth $1.86M as of Q1 2026.
  • UBS Group sold 282,372 Avanos Medical shares in Q1 2026, an estimated $3.8M.
  • Avanos Medical made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5042 holding.
  • UBS Group first reported a position in Avanos Medical in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Avanos Medical position peaked at $10.2M in Q4 2014.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.